Search filters

Filters
Clear All

Phase

  • 4
  • 11
  • 10
  • 14
  • 3
  • 60
  • 103
  • 17
  • 2
  • 103
  • 104
  • 1

Found 105 medicine trials

A listing of medicine medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 The Penn Medicine BioBank
18 years - 100 years
All genders
Observational
The Penn Medicine Biobank is collecting and storing biological specimens such as blood, as well as health information from volunteers. These samples and this information allow researchers to use them for research studies including but not limited to COVID-19, cancer, diabetes, and heart disease.
 Digital Data and Heart Health | Using Digital Data to Predict Heart Disease
30 years - 74 years
All genders
Observational
What is the purpose of this study?   This research study is exploring about how digital data (ie. social media, online searches, and step tracking data) are associated with Coronary Heart Disease (CHD) and related risk factors in order to develop a more precise CHD risk predictor tool.   We …
 Blood Pressure and Outcomes in Contemporary Left Ventricular Assist Device Recipients (BP-LVAD)
18 years - 99 years
All genders
Observational
The purpose of the study is to identify the optimal blood pressure range and blood pressure medication regimen for persons supported by a HM3 LVAD, specifically to reduce the risk of stroke and death.
 Tobacco Product Advertising Study
21 years - 29 years
Accepts healthy volunteer
All genders
The University of Pennsylvania's Tobacco Use Research Center is recruiting young adults between the ages of 21-29 who use or have previously used cigarettes and other tobacco products for a research study evaluating reactions to tobacco product advertising. This is not a quit smoking study.
 Understanding the Genetics of Central Centrifugal Cicatricial Alopecia
99 years or below
All genders
The purpose of this study is to characterize gene mutations associated Central Centrifugal Cicatricial Alopecia (CCCA). The Penn Medicine BioBank (PMBB) supports researchers by providing centralized access to a large number of annotated blood and tissue samples. Clinician identified patients with CCCA and appropriate controls will be recruited from the …
 Comparative Effectiveness of Behavioral Interventions, Safety Devices, and Financial Incentives to Reduce Cellphone Use While Driving Among UBI Auto Policy Holders
18 years - 99 years
All genders
The purpose of this study is to test different behavioral strategies to see if they are effective at reducing cell phone use while driving among Progressive Usage-Based Insurance (UBI) Snapshot policy holders. Snapshot monitors driving habits and allows Progressive to provide insurance rates based on them. The present study uses …
18 years or above
Male
Phase 3
Interventional
This phase III trial tests two questions by two separate comparisons of therapies. The first question is whether enhanced therapy (apalutamide in combination with abiraterone + prednisone) added to standard of care (prostate radiation therapy and short term androgen deprivation) is more effective compared to standard of care alone in …
 RhIMAB Study
18 years - 99 years
All genders
Participation in this research study is presented as a voluntary option to those women presenting at Penn Medicine and choosing medication abortion. The research team seeks to asses the value of blood typing and the provision of Rh immune globulin to women choosing medication abortion at 10 weeks and 0 …
99 years or below
All genders
In the last decade, both the incidence and the survival of acute leukemia has been increasing. Therefore, detection of associated illnesses is important. We have recently observed that patients with acute leukemia treated with anthracyclines develop a high rate of symptomatic heart failure. To avoid this life-threatening illness, early detection …
 UPCC 22420: A Phase 1b Study of Subcutaneous Daratumumab Regimens in Combination with Bispecific T Cell Redirection Antibodies for the Treatment of Subjects with Multiple Myeloma
18 years - 99 years
All genders
Phase 1
The purpose of this study is to identify recommended Phase 2 doses (RP2Ds) for each treatment combination (between daratumumab plus talquetamab and teclistamab plus daratumumab) and to characterize the safety of each RP2D for selected treatment combinations. Patients from within the Penn Medicine Cancer Center will be approached as potential participants.
21 - 30 of 105